Participant Details
- Photo
- First Name
- Chris
- Last Name
- Porter
- Institution
- Monash
- Country
- AUS
- chris.porter@monash.edu
- Technologies/Techniques Used
- ADME profiling, Animal Models, Drug Formulation, LC-MS/MS, Physicochemical Characterization
- Research Interest
- Drug delivery, Drug transport, Immunotherapy, Intracellular trafficking, Lipid metabolism and transport, Lymph/lymphatic system, Nanomedicine, Obesity, Pharmacokinetics, Prodrugs
- Publication Profile
- scholar.google.com.au/citations?user=tdBms8IAAAAJ&hl=en
Personal Info
- Bio
- Chris Porter is Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University. MIPS houses over 400 researchers and graduate students across five major themes of activity in Pharmaceutical Sciences – drug discovery biology, medicinal chemistry, lead optimisation, drug delivery and medicine use and safety. Therapeutically, MIPS strengths lie in CNS disease, cardio-metabolic disease and global health. Chris’ personal research programs focus on understanding and quantifying the absorption, distribution and elimination profiles of drugs and on developing novel formulation approaches to optimise these profiles. A major interest has been in improving the absorption of poorly water soluble drugs and the role of the lymphatic system in drug absorption. His broader interests include mechanisms of intracellular drug transport and the potential utility of dendrimers and other nanomaterials as drug delivery systems. Chris has published more than 220 peer reviewed papers (>18,000 citations) in these areas and his research programs have attracted >$27m in funding from government and commercial organisations. He is an inventor on 18 separate patent families, five of which have been the subject of licencing/assignment deals with national and international pharma/biotech companies. He is a Clarivate Analytics highly cited researcher (2015, 2016 and 2018) and a fellow of the American Association of Pharmaceutical Scientists. He was awarded an honourary doctorate by Uppsala University in 2018 and the 2017 APSA medal by the Australasian Pharmaceutical Sciences Association. He is an Editorial Board member for Molecular Pharmaceutics, Pharmaceutical Research, the Journal of Pharmaceutical Sciences and the Journal of Pharmacy and Pharmacology, and is a previous elected member of the Board of Scientific Advisors of CRS.
- Website, Blog or Social Media Link
- Porter Group Web Page